COVID-19 preventive drug Evusheld has begun preparing for actual prescriptions. According to related industries, AstraZeneca's Evusheld passed the Drug Committee of 200 medical institutions nationwide, including the Big 5 Advanced General Hospitals such as Seoul National University Hospital and Samsung Medical Center through the Korea Centers for Disease Control and Prevention. In May, the government spent 39.6 billion won to introduce 20,000 doses of Evusheld, an antibody treatment for the purpose of preventing COVID-19 infections and severe diseases to protect severe immune deficiencies.

Since then, the Ministry of Food and Drug Safety has confirmed the emergency use approval of Evusheld on the 30th o